New findings of an Alliance Foundation Trials study show combining immunotherapy and chemotherapy before surgery improves outcomes for some patients with locally advanced non-small cell lung cancer, according to the results of AFT-16/CHIO3 published in Lung Cancer.
This article was originally published by MedicalXpress. For more details, images, and references:
Read Full Original Article ↗